#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>8.9 U/mL or less: Negative - No significant level of detectable IgG antibody to EBV early (D) antigen. 9.0-10.9 U/mL: Equivocal - Repeat testing in 10-14 days may be helpful. 11.0 U/mL or greater: Positive - IgG antibody to EBV early (D) antigen detected, which may indicate a current or past EBV infection.
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Interpretive information regarding serologic features of EBV-associated diseases is available at www.arupconsult.com/ebvdx .
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
EBV EA-D values obtained with different manufacturers' assay methods may not be used interchangeably. The magnitude of the reported EBV EA-D level cannot be correlated to an endpoint titer.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
86663
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
EBNA Antibody (Epstein-Barr Virus Antibody to Early D Antigen (EA-D), IgG), EBV Antibody to Early D Antigen (Epstein-Barr Virus Antibody to Early D Antigen (EA-D), IgG), EBV Nuclear Antibody (Epstein-Barr Virus Antibody to Early D Antigen (EA-D), IgG), Infectious Mononucleosis (Epstein-Barr Virus Antibody to Early D Antigen (EA-D), IgG) |
*ExistCrossReferences>